Premium
The inhibitory effect of caffeine on hormone‐induced rat breast cancer
Author(s) -
Petrek Jeanne A.,
Sandberg Wendy A.,
Cole Marlene N.,
Silberman Morton S.,
Collins Delwood C.
Publication year - 1985
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19851015)56:8<1977::aid-cncr2820560815>3.0.co;2-7
Subject(s) - caffeine , medicine , breast cancer , endocrinology , prolactin , dose , diethylstilbestrol , cancer , hormone , physiology , ingestion
Studies have associated coffee and/or caffeine with human fibrocystic breast disease. Two animal studies have implicated caffeine as a promoter in rat mammary cancer. The current investigation examines the effect of two caffeine doses in ACI rats with and without diethylstilbestrol (DES). Without DES, cancer did not develop in any of the rats receiving either of the two caffeine dosages. With DES, increasing caffeine dosage lengthened the time to first cancer, decreased the number of rats that developed cancers, and decreased the number of cancers overall. The presence or amount of caffeine did not cause detectable histologic differences in the breast cancers. The presence or amount of caffeine did not influence animal weight or mortality, although the rats without DES weighed more and survived better into old age. The presence or amount of caffeine did not influence pituitary weights and prolactin levels, although values of the DES groups were three times higher than the values for the group without DES ( P < 0.05). In conclusion, chronic caffeine ingestion inhibits rat breast cancer, neither by interfering with the high prolactin levels—a necessary step in murine tumor development—nor by causing hypocaloric intake. Cancer 56: 1977‐1981, 1985.